These compounds were able to antagonize PPARα at low micromolar concentrations, and displayed also interesting antiproliferative effects when tested in paraganglioma, glioblastoma, colorectal and pancreatic cancer cell models [14,15]. The gene discussed is PPARA; the disease is paraganglioma.